Last reviewed · How we verify

NCT05133115: FRAK

Fostering Resilience in Adolescents at Risk.

Completed NA Last updated 8 February 2023
What this trial tests

NA trial testing Fostering Resilience in Adolescents at Risk in Resilience, Psychological in 674 participants. Completed in 31 December 2022.

Timeline
30 January 2022
Primary endpoint
30 June 2022
31 December 2022

Quick facts

Lead sponsorConsorci Sanitari de Terrassa
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment674
Start date30 January 2022
Primary completion30 June 2022
Estimated completion31 December 2022
Sites8 locations across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Consorci Sanitari de Terrassa — full company profile →

Who can join

Adults 12 to 15, any sex, with Resilience, Psychological. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess the effectiveness of a school-based resilience intervention in adolescents and to understand whether the school training can improve levels of resilience or psychological wellbeing, while reducing depressed mood.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effectiveness of a resilience school-based intervention in adolescents at risk: a cluster-randomized controlled trial.
    Llistosella M, Castellví P, García-Ortiz M, López-Hita G, et al · · 2024 · cited 8× · PMID 39502155 · DOI 10.3389/fpsyg.2024.1478424

Verify or expand the search:

Other recruiting trials for Resilience, Psychological

Currently open trials in the same condition.

Other Consorci Sanitari de Terrassa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05133115.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing